Department of Molecular Oncology,
Cancer Research Institute,
Department of Molecular Oncology, Cancer Research Institute
Bozena Smolkova has not added Biography.
If you are Bozena Smolkova and would like to personalize this page please email our Author Liaison for assistance.
NBN and XRCC3 genetic variants in childhood acute lymphoblastic leukaemia.
Cancer epidemiology Oct, 2014 | Pubmed ID: 25176580
Genetic determinants of quantitative traits associated with cardiovascular disease risk.
Mutation research Aug, 2015 | Pubmed ID: 26043189
Expression of SOCS1 and CXCL12 Proteins in Primary Breast Cancer Are Associated with Presence of Circulating Tumor Cells in Peripheral Blood.
Translational oncology Jun, 2016 | Pubmed ID: 27267835
Nanomedicine and epigenome. Possible health risks.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association Nov, 2017 | Pubmed ID: 28705729
Immunotoxicity, genotoxicity and epigenetic toxicity of nanomaterials: New strategies for toxicity testing?
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association Nov, 2017 | Pubmed ID: 28847762
Inflammation-Based Scores Increase the Prognostic Value of Circulating Tumor Cells in Primary Breast Cancer.
Cancers May, 2020 | Pubmed ID: 32369910
Epigenetic Landscape in Pancreatic Ductal Adenocarcinoma: On the Way to Overcoming Drug Resistance?
International journal of molecular sciences Jun, 2020 | Pubmed ID: 32521716
Intracellular prodrug gene therapy for cancer mediated by tumor cell suicide gene exosomes.
International journal of cancer Jan, 2021 | Pubmed ID: 32621791
Targeting Epigenetic Modifications in Uveal Melanoma.
International journal of molecular sciences Jul, 2020 | Pubmed ID: 32726977
Validating fPSA Glycoprofile as a Prostate Cancer Biomarker to Avoid Unnecessary Biopsies and Re-Biopsies.
Cancers Oct, 2020 | Pubmed ID: 33076457
Epigenetics in Breast Cancer Therapy-New Strategies and Future Nanomedicine Perspectives.
Cancers Dec, 2020 | Pubmed ID: 33287297
Increased Stromal Infiltrating Lymphocytes Are Associated with the Risk of Disease Progression in Mesenchymal Circulating Tumor Cell-Positive Primary Breast Cancer Patients.
International journal of molecular sciences Dec, 2020 | Pubmed ID: 33322711
Decreased levels of circulating cytokines VEGF, TNF-β and IL-15 indicate PD-L1 overexpression in tumours of primary breast cancer patients.
Scientific reports Jan, 2021 | Pubmed ID: 33446741
Targeting the gut microbiome: An emerging trend in hematopoietic stem cell transplantation.
Blood reviews Jul, 2021 | Pubmed ID: 33573867
The hCOMET project: International database comparison of results with the comet assay in human biomonitoring. Baseline frequency of DNA damage and effect of main confounders.
Mutation research. Reviews in mutation research , 2021 | Pubmed ID: 34083035
DNA Repair Gene Polymorphisms and Chromosomal Aberrations in Exposed Populations.
Frontiers in genetics , 2021 | Pubmed ID: 34220964
DNA damage in circulating leukocytes measured with the comet assay may predict the risk of death.
Scientific reports Aug, 2021 | Pubmed ID: 34408182
Author Correction: DNA damage in circulating leukocytes measured with the comet assay may predict the risk of death.
Scientific reports Sep, 2021 | Pubmed ID: 34545156
Chemotherapy-triggered changes in stromal compartment drive tumor invasiveness and progression of breast cancer.
Journal of experimental & clinical cancer research : CR Sep, 2021 | Pubmed ID: 34579743
miR-205-5p Downregulation and Upregulation Characterize the Disseminated Tumor Cells in Patients with Invasive Ductal Breast Cancer.
International journal of molecular sciences Dec, 2021 | Pubmed ID: 35008529
Decitabine potentiates efficacy of doxorubicin in a preclinical trastuzumab-resistant HER2-positive breast cancer models.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie Mar, 2022 | Pubmed ID: 35091237
A pooled analysis of molecular epidemiological studies on modulation of DNA repair by host factors.
Mutation research. Genetic toxicology and environmental mutagenesis , 2022 | Pubmed ID: 35483778
Decitabine-induced DNA methylation-mediated transcriptomic reprogramming in human breast cancer cell lines; the impact of DCK overexpression.
Frontiers in pharmacology , 2022 | Pubmed ID: 36278182
Liquid biopsy and preclinical tools for advancing diagnosis and treatment of patients with pancreatic neuroendocrine neoplasms.
Critical reviews in oncology/hematology Dec, 2022 | Pubmed ID: 36334880
The Metastatic Process through the Eyes of Epigenetic Regulation: A Promising Horizon for Cancer Therapy.
International journal of molecular sciences Dec, 2022 | Pubmed ID: 36555088
Genotoxic effects of occupational exposure to glass fibres - A human biomonitoring study.
Mutation research. Genetic toxicology and environmental mutagenesis Jan, 2023 | Pubmed ID: 36669817
Jesús Frutos Díaz-Alejo*,1,2,3,4,
Simon April-Monn*,5,
Marina Cihova6,
Verona Buocikova6,
Jorge Villalón López1,3,
Maria Urbanova6,
Carmen G. Lechuga7,
Miroslav Tomas6,8,
Peter Dubovan6,8,
Bárbara Luna Sánchez3,
Sonia Camaño Páez3,
Alfonso Sanjuanbenito2,9,
Eduardo Lobo9,
Estefanía Romio de la Heras10,
Carmen Guerra2,7,
Carolina de la Pinta11,
Emma Barreto Melian1,2,
Mercedes Rodríguez Garrote1,2,
Alfredo Carrato1,2,4,
Laura Ruiz-Cañas3,12,13,
Bruno Sainz, Jr.2,3,12,13,
Ana Torres3,
Bozena Smolkova6,
Julie Earl1,2,3
1Molecular Epidemiology and Predictive Tumor Markers Group, Area 3, Ramón y Cajal Health Research Institute (IRYCIS),
2, The Biomedical Research Network in Cancer (CIBERONC),
3Biobank and Biomodels Platform (PT20/0045), ISCIII research and development platforms in biomedicine and health sciences, BioBank Hospital Ramón y Cajal-IRYCIS, Spanish National Biobanks Network (ISCIII Biobank Register No. B.0000678), Ramón y Cajal Health Research Institute (IRYCIS),
4Faculty of Medicine, University of Alcalá de Henares,
5Institute of Tissue Medicine and Pathology, University of Bern,
6Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences,
7Experimental Oncology, Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas (CNIO),
8Department of Surgical Oncology, National Cancer Institute, Slovak Medical University,
9Pancreatic and Biliopancreatic Surgery Unit, Hospital Universitario Ramón y Cajal,
10Department of Pathology, Hospital Universitario Ramón y Cajal,
11Department of Radiation Oncology, Hospital Universitario Ramón y Cajal,
12Department of Cancer, Instituto de Investigaciones Biomédicas “Alberto Sols” (IIBM),
13Cancer Stem Cell and Fibroinflammatory Group, Chronic Diseases and Cancer, Area 3, IRYCIS
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유